Abstract
Hereditary tyrosinaemia type I is a devastating autosomal recessive metabolic disorder, which, if untreated, causes liver failure, rickets, painful neurological crisis and hepatocellular carcinoma. With the advent of 2-(2-nitro-4 trifluoromethylbenzoyl) -1,3 cyclohexanedione, the outcome of hereditary tyrosinaemia type I has significantly improved; however this treatment is very expensive. For early diagnosis of hereditary tyrosinaemia type I, a high index of suspicion is required in children presenting with hepatomegaly, significantly raised alpha-fetoprotein and multiple focal hepatic masses. Children with untreated disease often succumb to the illness within the first 2 years of life.
Original language | English |
---|---|
Pages (from-to) | 1044-1046 |
Number of pages | 3 |
Journal | Journal of the Pakistan Medical Association |
Volume | 63 |
Issue number | 8 |
Publication status | Published - Aug 2013 |
Keywords
- Focal hepatic lesion
- Pakistani children
- Tyrosinaemia type I